Biotron Past Earnings Performance
Past criteria checks 0/6
Biotron's earnings have been declining at an average annual rate of -2.6%, while the Biotechs industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 22.9% per year.
Key information
-2.6%
Earnings growth rate
6.0%
EPS growth rate
| Biotechs Industry Growth | 9.6% |
| Revenue growth rate | 22.9% |
| Return on equity | n/a |
| Net Margin | -208.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Feb 27
We Think Biotron (ASX:BIT) Can Afford To Drive Business Growth
Oct 20We're Not Worried About Biotron's (ASX:BIT) Cash Burn
Jul 06Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jan 18Will Biotron (ASX:BIT) Spend Its Cash Wisely?
Jul 06Here's Why We're Watching Biotron's (ASX:BIT) Cash Burn Situation
Mar 17Here's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn Situation
Nov 27Biotron (ASX:BIT) Is In A Good Position To Deliver On Growth Plans
May 26We're Not Very Worried About Biotron's (ASX:BIT) Cash Burn Rate
Feb 10What Can We Conclude About Biotron's (ASX:BIT) CEO Pay?
Dec 19Revenue & Expenses Breakdown
How Biotron makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -3 | 1 | 4 |
| 31 Mar 24 | 2 | -4 | 1 | 4 |
| 31 Dec 23 | 2 | -4 | 1 | 4 |
| 30 Sep 23 | 2 | -4 | 2 | 4 |
| 30 Jun 23 | 1 | -3 | 2 | 3 |
| 31 Mar 23 | 2 | -3 | 1 | 3 |
| 31 Dec 22 | 3 | -2 | 1 | 3 |
| 30 Sep 22 | 2 | -2 | 1 | 3 |
| 30 Jun 22 | 2 | -3 | 1 | 3 |
| 31 Mar 22 | 1 | -3 | 1 | 3 |
| 31 Dec 21 | 1 | -3 | 1 | 3 |
| 30 Sep 21 | 1 | -3 | 1 | 3 |
| 30 Jun 21 | 1 | -3 | 1 | 3 |
| 31 Mar 21 | 1 | -4 | 1 | 3 |
| 31 Dec 20 | 1 | -4 | 1 | 3 |
| 30 Sep 20 | 1 | -4 | 1 | 3 |
| 30 Jun 20 | 1 | -4 | 1 | 3 |
| 31 Mar 20 | 0 | -3 | 1 | 2 |
| 31 Dec 19 | 0 | -3 | 1 | 2 |
| 30 Sep 19 | 1 | -3 | 1 | 2 |
| 30 Jun 19 | 1 | -2 | 1 | 1 |
| 31 Mar 19 | 1 | -2 | 1 | 1 |
| 31 Dec 18 | 1 | -2 | 1 | 1 |
| 30 Sep 18 | 1 | -2 | 1 | 1 |
| 30 Jun 18 | 2 | -2 | 1 | 2 |
| 31 Mar 18 | 2 | -1 | 1 | 2 |
| 31 Dec 17 | 3 | -1 | 1 | 3 |
| 30 Sep 17 | 2 | -2 | 1 | 3 |
| 30 Jun 17 | 2 | -3 | 1 | 3 |
| 31 Mar 17 | 2 | -3 | 1 | 3 |
| 31 Dec 16 | 2 | -2 | 1 | 2 |
| 30 Sep 16 | 2 | -3 | 1 | 3 |
| 30 Jun 16 | 2 | -3 | 1 | 3 |
| 31 Mar 16 | 2 | -3 | 1 | 3 |
| 31 Dec 15 | 2 | -3 | 1 | 3 |
| 30 Sep 15 | 2 | -3 | 1 | 3 |
| 30 Jun 15 | 2 | -3 | 1 | 3 |
| 31 Mar 15 | 2 | -3 | 1 | 3 |
| 31 Dec 14 | 2 | -3 | 1 | 3 |
| 30 Sep 14 | 2 | -3 | 1 | 3 |
| 30 Jun 14 | 2 | -3 | 1 | 3 |
| 31 Mar 14 | 1 | -4 | 1 | 3 |
| 31 Dec 13 | 1 | -4 | 1 | 4 |
Quality Earnings: BIT is currently unprofitable.
Growing Profit Margin: BIT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIT is unprofitable, and losses have increased over the past 5 years at a rate of 2.6% per year.
Accelerating Growth: Unable to compare BIT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (2.6%).
Return on Equity
High ROE: BIT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.